A Designed Phenylalanyl-tRNA Synthetase Variant Allows Efficient in Vivo Incorporation of Aryl Ketone Functionality into Proteins
- 26 April 2002
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 124 (20) , 5652-5653
- https://doi.org/10.1021/ja0177096
Abstract
Incorporation of non-natural amino acids into proteins in vivo expands the scope of protein synthesis and design. p-Acetylphenylalanine was incorporated into recombinant dihydrofolate reductase (DHFR) in Escherichia coli via a computationally designed mutant form of the phenylalanyl-tRNA synthetase of the host. DHFR outfitted with ketone functionality can be chemoselectively ligated with hydrazide reagents under mild conditions.Keywords
This publication has 19 references indexed in Scilit:
- Crystal structures of phenylalanyl-tRNA synthetase complexed with phenylalanine and a phenylalanyl-adenylate analogueJournal of Molecular Biology, 1999
- Expansion of the genetic code: Site‐directed p‐fluoro‐phenylalanine incorporation in Escherichia coliProtein Science, 1998
- Site-Specific Protein Modification Using a Ketone HandleJournal of the American Chemical Society, 1996
- Relaxing the substrate specificity of an aminoacyl‐tRNA synthetase allows in vitro and in vivo synthesis of proteins containing unnatural amino acidsFEBS Letters, 1995
- Total Chemical Synthesis of a Unique Transcription Factor-Related Protein: cMyc-MaxJournal of the American Chemical Society, 1995
- Substrate Specificity Is Determined by Amino Acid Binding Pocket Size in Escherichia coli Phenylalanyl-tRNA SynthetaseBiochemistry, 1994
- Facile synthesis of homogeneous artificial proteinsJournal of the American Chemical Society, 1994
- Self-Assembling Drugs: A New Approach to Biochemical Modulation in Cancer ChemotherapyCancer Investigation, 1994
- Amino acid substrate specificity of Escherichia coli phenylalanyl-tRNA synthetase altered by distinct mutationsJournal of Molecular Biology, 1991
- Synergism through direct covalent bonding between agents: A strategy for rational design of chemotherapeutic combinationsBiopolymers, 1990